Insider Transactions

What Calithera Biosciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Pakianathan Deepika	Director	Jan 27	Open-market sale · S	−1,172	$0.39	−$452	0
Pakianathan Deepika	Director	Jan 27	Open-market sale · S	−120,161	$0.39	−$46.4K	0
Molineaux Susan	PRESIDENT & CEO	Jan 23	Withheld — tax / exercise cost · F	−526	$0.45	−$235	27,859
Kuriakose Emil	CHIEF MEDICAL OFFICER	Jan 23	Withheld — tax / exercise cost · F	−79	$0.45	−$35.2	3,539
Wong Stephanie	See Remarks	Jan 23	Withheld — tax / exercise cost · F	−317	$0.45	−$141	6,287
Molineaux Christopher	SR. VP, DEVELOPMENT	Jan 23	Withheld — tax / exercise cost · F	−217	$0.45	−$96.8	27,859
Sjogren Eric	SR. VP, DRUG DISCOVERY	Jan 23	Withheld — tax / exercise cost · F	−279	$0.45	−$124	8,467
Kuriakose Emil	CHIEF MEDICAL OFFICER	Jan 21	Withheld — tax / exercise cost · F	−666	$0.49	−$327	67,369
Sjogren Eric	SR. VP, DRUG DISCOVERY	Jan 21	Withheld — tax / exercise cost · F	−4,794	$0.49	−$2.36K	172,434
Wong Stephanie	See Remarks	Jan 21	Withheld — tax / exercise cost · F	−5,586	$0.49	−$2.75K	132,085
Parlati Francesco	SR. VP, RESEARCH	Jan 21	Withheld — tax / exercise cost · F	−4,794	$0.49	−$2.36K	140,998
Kuriakose Emil	CHIEF MEDICAL OFFICER	Jan 04	Withheld — tax / exercise cost · F	−3,855	$0.66	−$2.55K	68,035
Sjogren Eric	SR. VP, DRUG DISCOVERY	Jan 04	Withheld — tax / exercise cost · F	−18,077	$0.66	−$11.9K	177,228
Wong Stephanie	See Remarks	Jan 04	Withheld — tax / exercise cost · F	−18,077	$0.66	−$11.9K	137,671
Parlati Francesco	SR. VP, RESEARCH	Jan 04	Withheld — tax / exercise cost · F	−18,077	$0.66	−$11.9K	145,792
Orford Keith	Director	Nov 11	Open-market sale · S	−48,190	$0.88	−$42.4K	66,094
Molineaux Susan	PRESIDENT & CEO	Nov 10	Open-market buy · P	+100,000	$0.85	+$84.7K	557,188
Molineaux Christopher	SR. VP, DEVELOPMENT	Nov 10	Open-market buy · P	+100,000	$0.85	+$84.7K	557,188
Drachman Jonathan G	Director	Nov 10	Open-market buy · P	+200,000	$0.86	+$172K	200,000
Orford Keith	Director	Nov 10	Open-market sale · S	−30,000	$0.86	−$25.7K	114,284

Page 1 of 10 · showing the 20 most recent Sign up free to view all 184 transactions and filter by insider →

Comments